# Emtricitabine and tenofovir disoproxil fumarate

NDC: 31722-560
Generic name: Emtricitabine and tenofovir disoproxil fumarate
Labeler / Manufacturer: Camber Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20211007

FDA application: ANDA201806

## Active ingredients

- EMTRICITABINE: 200 mg/1
- TENOFOVIR DISOPROXIL FUMARATE: 300 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"31722-560"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=31722-560
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7fa6961e-3602-4e31-a60a-e5735899f63b